• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

So let's get this straight. You are laying off but won't say when?

Quote




Sites have already turned us away and want nothing to do with Aduhelm or Biogen. I agree it is over. No more lunches. No more appointments. The hospitals do not want to be study sites either as the drug is already tainted beyond fixable.
I also believe Biogen will not follow-through with a clinical trial as they already know what the dreadful results would be of said study. Expect a 3 to 6 month "show and tell" to the general public and media that they are proceeding with a clinical trial only later to pull completely out of the whole thing and abandon the drug.
 








They want you to quit first to avoid severance. I think that it will be done before the May 3 earnings call at the latest, They have to be accountable to investors. Paying us to sit on our asses for a month after the NCD decision will just make them look even worse.
 








It takes time to bury the dead bodies and buy off enemies who know too much. And Biogen has made a lot of enemies in the last 5 years. Lawyers cant just go around photocopying capellos separation payoff.

Be patient. An unwavering commitment is all that is left. Just find me an unwavering frenchman.
 




Top Bottom
Back
Quote